Research from University of Illinois Cancer Center members, trainees, co-authors and others at the University of Illinois Chicago (UIC), including its regional campuses in Rockford and Peoria, will be featured at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 30 to June 3. A listing of their abstracts is below.
Other ASCO Details
- The Cancer Center has partnered with Common Sense Oncology (CSO) to host a special pre-ASCO Symposium. Click this link to register. Speakers at the Friday, May 30, event are ASCO Chief Medical Officer Julie Gralow, MD; Cancer Center member and Medical Oncologist Abiola Ibraheem, MD; CSO Co-Founders Christopher Booth, MD, FRCPC, and Bishal Gyawali, MD, PhD; and Medical Oncologist Ian Tannock, MD, PhD. The symposium will be held at Student Center West on the UIC campus, 828 S. Wolcott Avenue.
- During the ASCO meeting, please visit the Cancer Center in the Exhibit Hall at Booth #10023 in the McCormick Place South Building.
List of Abstracts
Area deprivation index and EGFR-mutated non-small-cell lung cancer Michael Weinfeld, Li Liu, Andrew Boyd, Aseem Aseem, Mary Pasquinelli, Noor Naffakh, Ameen Salahudeen, Frank Weinberg, Vk Gadi, Ryan Nguyen
Clinical implications of HER3 overexpression in a diverse patient cohort with prostate cancer Hannah Maluvac, Jordan Vellky, Karine Tawagi, Donald Vander Griend, Natalie Reizine
Implementation of a fellow-led tumor board to enhance learning and support in fellow continuity clinic Neha Hippalgaonkar, Ahmad Nassar, Karine Tawagi
Structural classification of FOXA1 alterations and their association with clinical outcomes and transcriptional profiles in prostate cancer patients Jordan Vellky, Ann Ayzman, Pornlada Likasitwatanakul, Aseem Aseem, Hannah Maluvac, Weiwei Ma, Zhengjia Chen, Karine Tawagi, Steve Kregel, Justin Hwang, Donald Vander Griend, Melissa Reimers, Emmanuel Antonarakis, Natalie Reizine
Race/ethnicity reporting and representation in clinical trials presented at the American Society of Clinical Oncology (ASCO) presidential plenaries from 2014 to 2024 Bingtao Xiang, Ana Maria Avila Rodriguez, Aseem Aseem, Abiola Ibraheem, Vk Gadi, Ryan Nguyen
Association of West African ancestry, reproductive factors, and deprivation with incidence of triple-negative breast cancer among Black women in the U.S. Neha Hippalgaonkar, Gregory Calip, Zain Akbar, Kent Hoskins
Abstracts Discussion: Rethinking Cancer Care Guidelines and Cancer Screening for Resource-Limited Countries Abiola Ibraheem, MD
Chemotherapy and supportive care practice patterns among older adults with metastatic pancreatic cancer Charles Gaber, Abdullah Abdelaziz, Ida Johannsen, Jakob Kirkegård, Todd Lee, Aaron Winn, Ryan Nipp
Developing and implementing a fellow-driven communication skills curriculum in hematology/oncology training Ahmad Nassar, Puneet Raman, Karine Tawagi
Prevalence of obesity/overweight and its relationship with incidence of pancreatic cancer in the US states using BRFSS and CDC WONDER database of 2021 Ahsan Wahab, Insia Rizvi, Karine Tawagi
Lipid metabolic gene expression and association with decreased overall survival and immunogenicity in KRAS-STK11 NSCLC Joshua Pothen, Jen Godden, Denise Shieh, Stamatina Fragkogianni, Jacob Mercer, Melissa Stoppler, Daniel Principe, Ryan Nguyen, Kamya Sankar, Koosha Paydary, Mary Fidler, Frank Weinberg
Communication skills training (CST) in hematology/oncology fellowships: Results from a multi-institutional needs assessment survey Ahmad Nassar, Puneet Raman, Ronak Mistry, Anna Wing, Kathryn McGrath, Amishi Shah, Tammarah Sklarz, Layla Van Doren, Thejal Srikumar, Rakesh Mehta, Erin Reid, Ida Wong, Vivek Patel, Karine Tawagi
Impact of tobacco use and sociodemographic factors on mortality in pancreatic cancer in the United States: A time trend analysis Muhammad Hisham Khan Wazir, Muhammad Faisal Aslam, Asfand Yar Cheema, Ahsan Wahab, Muhammad Abdullah Wazir
The association between profitability, clinical benefit, and physicians’ selection of cancer drugs Aaron Mitchell, Stacie Dusetzina, Akriti Mishra Meza, Grace Gallagher, Patrick Augello, Hannah Fuchs, Gabrielle Guzman, Abdullah Abdelaziz, Sara Tabatabai, Sonia Persaud, Nirjhar Chakraborty, Andrew Epstein, Robert Daly, Aaron Winn, Mithat Gonen
Adjuvant cisplatin regimens for locoregionally advanced head and neck squamous cell carcinoma: A meta-analysis Amna Gul, Jean-Pierre Obeid, Arslan Inayat, Mustafa Samejo, Asfand Yar Cheema, Sumbal Aziz, Smit Modi, Noah Kalman
Feasibility of door-to-door HPV DNA screening using self-collected vaginal swabs for early detection of cervical cancer in rural India Shailendra Dandge, Kalpana Betha, Sameer Valsangkar, Lifang Hou, Supriya Mehta
Linking comfort levels and knowledge gaps in hematology/oncology (HO) fellowship education: Insights from a multicenter survey Ronak Mistry, Karine Tawagi, Samantha Armstrong, Daniel Hausrath, Inas Abuali, Dillon Cockrell, Kayla Miranda, Ahmad Nassar, Yurhee Lee, Victoria Chung, Fadi Taza, Matthew Bloom, Daniel Egert, Giuliana Berardi, Madeline Fitzpatrick, Aleena Itani, Ericson Stoen, Nathaniel Wilson, Vivek Patel
Comparative meta-analysis of cisplatin dosing schedules in definitive chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma Amna Gul, Arslan Inayat, Jean-Pierre Obeid, Muhammad Atif Khan, Asfand Yar Cheema, Sumbal Aziz, Smit Modi, Mustafa Samejo, Noah Kalman
A phase II study of niraparib (N), abiraterone acetate (AA) plus prednisone (P) for Hispanic/Latino (HL) and non-Hispanic Black (NHB) patients with metastatic hormone sensitive prostate cancer (mHSPC) and deleterious homologous recombination repair alterations (HRRa; HARMONY) Qian Qin, Changchuan Jiang, Song Zhang, Suzanne Cole, Kevin Courtney, Jue Wang, Waddah Arafat, Joseph Vento, Karine Tawagi, Natalie Reizine, Marijo Bilusic, Molly McGuire, Amy Rowell, David Wise, Melissa Reimers, Elisabeth Heath, Tian Zhang
Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX Erin Cobain, Priyanka Sharma, Kent Hoskins, Michael Berry, Gregory Vidal, J. Jaime Alberty-Oller, Nicole Gordon, Harshini Ramaswamy, Nicole Stivers, Andrea Menicucci, William Audeh, Joyce O’Shaughnessy
Representation in clinical trials evaluating lifestyle interventions targeting energy balance in cancer survivors: A scoping review Alexandra Rich, Aarifah Bandealy, Q Wafford, Brendan Hickey, Payton Solk, Julia Starikovsky, Kristina Hasanaj, Shirlene Wang, Julia Frey, Siobhan Phillips, Jean Reading
Preferred first-line (1L) treatment for metastatic urothelial carcinoma (mUC) after prior immune checkpoint inhibitor (ICI) therapy: Results from a national survey Ali Khaki, Priyanka Chablani, Karine Tawagi, Petros Grivas, Jeannie Hoffman-Censits, Matthew Galsky, Shilpa Gupta, Vadim Koshkin, Elizabeth Plimack, Jonathan Rosenberg, Peter O’Donnell
Integration of a podcast curriculum (PC) to improve hematology oncology fellow (HOF) knowledge: A multi-center cluster randomized control trial Vivek Patel, Karine Tawagi, Samantha Armstrong, Daniel Hausrath, Inas Abuali, Sean Taasan, Ankoor Biswas, Jonathan Berry, Srijan Valasapalli, Kyle Kidwell, Agrima Mian, Shivang Danak, Moriah Forster, Jessica Stempel, Pranali Pachika, Maya Abdallah, Sheila DeYoung, Lauren Mendelson, Megan Melody, Ronak Mistry
Economic evaluation of work productivity gains associated with ribociclib (RIB) in hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) early breast cancer (EBC) in the United States Adam Brufsky, Joseph Sparano, Sara Tolaney, Vk Gadi, Jason Shafrin, Xinglei Chai, Fan Yang, Zheng-Yi Zhou, Vaidyanathan Ganapathy, Corinth Auld, Gary Sopher, Emma Alexander, Vamsi Bollu, Louis Garrison
The role of LYCAT in EGFR-TKI resistance, NSCLC progression, and smoking-induced lung cancer Stephanie Lopez, Stephanie Wu, Namrata Dubey, S Nasifuzzaman, Robert Hillwig, Neelu Puri
Targeting melanoma cells through G-quadruplex formation: Mechanism and enhanced efficacy of T-oligo in combination therapy Rose Bahari, Lawrence Miller, Hyatt Alaraj, Archit Agnihotri, Neelu Puri
Trends in mantle cell lymphoma: Updated SEER analysis from 2000 to 2021 Ruby Arora, Nakhle Saba
The risk of venous and arterial thrombosis in polycythemia vera patients with secondary malignancies Christina Carfagnini, Eugene Annor, Rishabh Singh, Simon Bechara, Gregory Gerstner, Manasa Kandula
The role of a suspicion of cancer clinic in lung cancer care Matthew Crimmins, Shawn Seibert, Trevella Fleming
Comparative efficacy and safety of CAR T-cell therapy versus standard of care for relapsed/refractory diffuse large B-cell lymphoma: A meta-analysis Nneoma Ubah, Suchith Boodgere Suresh, Muhammad Wazir, Chidiebube Ugwu, Eugene Annor, Gogo Ibodeng, Anup Kasi
Late effects in high-risk neuroblastoma survivors who received MIBG therapy Prerna Kumar, Margaret Cupit-Link, Sara Federico, Jenna Bardwell, Steven DuBois, Pei-Chi Kao, Wendy London, Lisa Diller, Tara Henderson
Metabolic-only response assessment for omission of residual node radiation therapy (RNRT) for patients with classical Hodgkin lymphoma (cHL) and impact on event free (EFS) and overall survival (OS): A report from the Pediatric Hodgkin Consortium’s phase 2 study cHOD17 (NCT03755804) Jamie Flerlage, Angela Feraco, Yiwang Zhou, Ying Zheng, John Lucas Jr., Jessi Rogers-Blake, Lindsay Wilemon, Bryan Roberts, Lianna Marks, Alison Friedmann, Shannon MacDonald, Howard Weinstein, Pedro De Alarcon, Eric Larsen, Torunn Yock, Susan Hiniker, Christine Bolen, Stephan Voss, Michael Link, Matthew Ehrhardt